MR Image Synthesis With Low Gadobutrol Dose and AI

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

July 7, 2025

Study Completion Date

August 15, 2025

Conditions
Enhancing Brain Lesions
Interventions
DEVICE

SubtleGAD

SubtleGAD is an image processing software developed to enhance MR images acquired with low dose gadobutrol.

DRUG

Gadobutrol

Gadavist is indicated for use with magnetic resonance imaging (MRI) in adult and pediatric patients including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system.

Trial Locations (5)

16801

The Pennsylvania State University, State College

55905

Mayo Clinic, Rochester

61637

Central Illinois Radiological Associates; OSF St. Francis Hospital Peoria, Peoria

77030

MD Anderson Cancer Center, Houston

01655

UMass Chan Medical School, Worcester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Subtle Medical

INDUSTRY

NCT06224543 - MR Image Synthesis With Low Gadobutrol Dose and AI | Biotech Hunter | Biotech Hunter